What is Double Helix?
Double Helix Optics specializes in nanoscale 3D imaging and sensing technologies, utilizing Nobel Prize-winning methods for super-resolution microscopy. Their core offerings include the SPINDLE modules and 3DTRAX software, which facilitate high-precision imaging of biological samples at the molecular level. The company caters to a broad spectrum of scientific clients, including those engaged in cell biology, disease discovery, and neuroscience research. By providing these sophisticated imaging solutions, Double Helix Optics is positioned to accelerate scientific research and foster innovation within the life sciences sector.
How much funding has Double Helix raised?
Double Helix has raised a total of $1.1M across 2 funding rounds:
Other Financing Round
$1M
Debt
$106K
Other Financing Round (2018): $1M, investors not publicly disclosed
Debt (2021): $106K led by PPP
Key Investors in Double Helix
PPP
Public-Private Partnership
What's next for Double Helix?
The recent major strategic investment signals a pivotal growth phase for Double Helix Optics. This capital infusion is expected to fuel further development of their proprietary super-resolution microscopy techniques and expand their market reach. The company's focus on enabling molecular-level imaging suggests potential applications in drug discovery, diagnostics, and advanced materials science, positioning them for significant contributions to scientific and technological advancements.
See full Double Helix company page
